Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dana Wolf

Showing results (51-60 of 52) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 52 results.
Med (New York, N.Y.)|June 18, 2022
B cell-derived cfDNA after primary BNT162b2 mRNA vaccination anticipates memory B cells and SARS-CoV-2 neutralizing antibodiesIlana Fox-Fisher, Sheina Piyanzin, Mayan Briller, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|October 22, 2022
Cytomegalovirus in the transplant setting: Where are we now and what happens next? A report from the International CMV Symposium 2021Camille N Kotton, Julián Torre-Cisneros, , et al.
Pageof 6

Showing results (51-60 of 52) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 52 results.
Med (New York, N.Y.)|June 18, 2022
B cell-derived cfDNA after primary BNT162b2 mRNA vaccination anticipates memory B cells and SARS-CoV-2 neutralizing antibodiesIlana Fox-Fisher, Sheina Piyanzin, Mayan Briller, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|October 22, 2022
Cytomegalovirus in the transplant setting: Where are we now and what happens next? A report from the International CMV Symposium 2021Camille N Kotton, Julián Torre-Cisneros, , et al.
Pageof 6